Skip to main content
. 2019 Nov 20;2019(11):CD003511. doi: 10.1002/14651858.CD003511.pub5

Klopper 1965.

Methods Unit of randomization: pregnancy
 Method of randomization: random schedules generated by a statistician
 Timing of randomization: before 10 weeks' gestation
 Power calculation: no
 Blinding: yes (double)
 Number of centers: 2
33 women randomized, 33 women analyzed
Source of funding: not stated
Participants Women who had ≥ 2 miscarriages, no pregnancy beyond 28 weeks' gestation, were < 10 weeks into the current pregnancy and with no other obvious causes of miscarriage
Interventions 50 mg twice daily of oral cyclopentyl enol ether of progesterone
Control: placebo
Duration: not stated
Outcomes Miscarriage
Notes Dates of study: not stated
Funding sources: somewhat unclear although the authors acknowledge "the firm of Vister who supplied the steroid and allowed their product to be subjected to a much more rigorous test than is usual in this field."
Declarations of interest: not stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Random schedules generated by statistician
Allocation concealment (selection bias) Unclear risk Given according to a random schedule
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Double‐blinded design ‐ neither participants nor physician knew which of the 2 they were getting.
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Not stated but likely blinded, but unlikely that knowledge of assignment would influence outcomes.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk None
Selective reporting (reporting bias) Low risk None
Other bias Low risk None